N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism
about
Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switchInfection of cells expressing CXCR4 mutants lacking N-glycosylation at the N-terminal extracellular domain is enhanced for R5X4-dualtropic human immunodeficiency virus type-1.IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platformAutologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeysHIV-1 tropism dynamics and phylogenetic analysis from longitudinal ultra-deep sequencing data of CCR5- and CXCR4-using variants.Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.Temporal analysis of HIV envelope sequence evolution and antibody escape in a subtype A-infected individual with a broad neutralizing antibody responseHIV-1 Transmission, Replication Fitness and Disease Progression.Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein regionDistinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16.Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop.Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaquesHuman immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations.Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization.Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivityV3-independent competitive resistance of a dual-X4 HIV-1 to the CXCR4 inhibitor AMD3100Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching.Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms.A strategy for O-glycoproteomics of enveloped viruses--the O-glycoproteome of herpes simplex virus type 1Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3.Isolation of CD4-independent primary human immunodeficiency virus type 1 isolates that are syncytium inducing and acutely cytopathic for CD8+ lymphocytes.Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques.Naturally Occurring Polymorphisms of the Mouse Gammaretrovirus Receptors CAT-1 and XPR1 Alter Virus Tropism and Pathogenicity.Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodiesEffect of Glycosylation on an Immunodominant Region in the V1V2 Variable Domain of the HIV-1 Envelope gp120 Protein.In silico Analysis of HIV-1 Env-gp120 Reveals Structural Bases for Viral Adaptation in Growth-Restrictive Cells.Genotypic prediction of HIV-1 CRF01-AE tropism.Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.Characterization of a dual-tropic human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2.A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction.N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.Phenotypic and genotypic characterization of human immunodeficiency virus type 1 CRF07_BC strains circulating in the Xinjiang Province of China.Removal of either N-glycan site from the envelope receptor binding domain of Moloney and Friend but not AKV mouse ecotropic gammaretroviruses alters receptor usage.The remarkable frequency of human immunodeficiency virus type 1 genetic recombinationHIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations.Enhanced fusion and virion incorporation for HIV-1 subtype C envelope glycoproteins with compact V1/V2 domainsRNA Sequencing Reveals Xyr1 as a Transcription Factor Regulating Gene Expression beyond Carbohydrate Metabolism.
P2860
Q24672335-85A2E98F-9314-4303-B4CF-3985EBA66A7FQ24794092-4568FF36-72AD-4869-91A9-084418DB2051Q28543211-04FF7BC4-589C-4FD9-A18A-7AB8CE2106CDQ28751926-4A00A8BF-2E70-47AF-99ED-B699B7146AA3Q30836893-83BE5944-B3A4-4D9A-AA51-090751FFBFE6Q31112947-08A3531D-5C3D-42DD-B02B-4DCFD299C10BQ31143293-73030549-DF45-400D-ACD4-685041EA1099Q33664910-27D1CBC0-9E02-497F-A209-8A3184F9A9A3Q33758570-CA9D94DD-EA87-46D6-8ADE-187A15966A77Q33853183-A4D36F23-30F8-43E2-8839-47FEA23E7089Q34055508-675AF5CC-0C40-4059-A7AB-E81C73181602Q34178201-A70EFB5F-CC85-42C5-8A72-8BD87F7F4A55Q34280044-BA5D6472-AD8D-4A86-966C-926097F79E22Q34301728-02BC36EA-ECFE-463D-9581-B6E83362099CQ34301803-2F9775DF-143F-4B7B-9952-628871B61F7EQ34553676-306D2801-7990-4C61-8CE9-3B0995614968Q34923915-CF92D529-67EB-470C-929C-F370B7DC980EQ35101464-670130FC-4EB1-4B05-89C5-8E79C8D3B83FQ35107518-BEE3D469-77BD-43A5-984D-7AFA0CEFB57AQ35122466-183AE3D1-2CF2-41E4-BBA0-537106E32E4EQ35161426-B60E5CE2-7E7B-4C82-BCD7-F4C4A0A5D099Q35242303-3E793D98-6AFE-4A08-A4B8-FF4B98300170Q35542887-5AD06901-D760-4A8B-9F72-C5B92466A5D1Q35543127-2A228F5E-1A5B-487B-8E57-0035FD29F366Q35636394-EE46D6EA-C1FB-461F-AC98-2A7CC3D77FB3Q35692374-F974C5D4-6466-46EF-B6A2-93F73D4B7EDEQ35857254-24F8A1B4-1901-489F-9822-1B750E74CAD5Q36157560-E97C923A-D009-43D6-B578-4B0F5B3782F8Q36558933-16651D75-CB6A-4B65-916D-4082FC949067Q36559004-F52FF142-C281-4E69-BB8D-17BA182937C4Q36608554-FE8485EF-4A21-4A03-8EA3-965A4404151AQ36674792-B7841A2F-BBB3-4DE0-A5CB-56F980422E32Q36926701-6C70A6E6-EF7B-4B98-8117-EFE9CFB9790FQ37010852-CE1C6B23-8882-4666-A119-62BBA987FCCAQ37220020-F26288ED-A404-425A-8A6B-6D64AFCAB8FAQ37319926-DAC17AEA-2556-49AB-93DE-348C87739C3DQ37333701-EB403776-0DF8-4FC1-AB5F-7FE6454DC4D4Q37525642-B41A539F-7A28-4C70-B85F-E1E4745053A0Q37547162-BF3954E6-9994-43A1-B331-10E0C832FF5BQ37575403-CC2335B3-BADA-4E26-8958-0DF8470D5B9D
P2860
N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
N-linked glycosylation sites a ...... tor usage and cellular tropism
@ast
N-linked glycosylation sites a ...... tor usage and cellular tropism
@en
type
label
N-linked glycosylation sites a ...... tor usage and cellular tropism
@ast
N-linked glycosylation sites a ...... tor usage and cellular tropism
@en
prefLabel
N-linked glycosylation sites a ...... tor usage and cellular tropism
@ast
N-linked glycosylation sites a ...... tor usage and cellular tropism
@en
P2093
P2860
P1433
P1476
N-linked glycosylation sites a ...... tor usage and cellular tropism
@en
P2093
P2860
P304
P356
10.1128/JVI.75.13.5998-6006.2001
P577
2001-07-01T00:00:00Z